AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
Byline: Jonah Keri
St. Jude Medical has surfed a strong uptrend for the last four years. Its latest base has lasted eight weeks, with volume drying up as the stock has drifted downward the past six days. Its Relative Strength line is in new high ground, a bullish sign.
The maker of devices used to treat cardiovascular disease has posted sales growth above 20% in three of the last four quarters. Profit growth climbed 28% and 21% in the last two quarters.
The Medical-Products group ranks 47th among the 197 industries tracked by IBD. St. Jude's Accumulation/Distribution Rating has surged to a B+ ...